Shui-ping ZHAO
Chinese Journal of Cardiology 2012;40(5):371-372
Anticholesteremic Agents ; adverse effects ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; adverse effects
Chinese Journal of Cardiology 2011;39(9):789-790
Coronary Disease ; etiology ; Humans ; Hypertriglyceridemia
Chinese Journal of Cardiology 2009;37(4):312-313
Coronary Disease ; prevention & control ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; therapeutic use ; Primary Prevention ; methods
Ya-qin CHEN ; Shui-ping ZHAO
Chinese Journal of Cardiology 2010;38(6):574-576
Cardiovascular Diseases ; drug therapy ; prevention & control ; Humans ; Hypolipidemic Agents ; administration & dosage ; therapeutic use ; Risk Reduction Behavior
Shui-ping ZHAO ; Ya-qin CHEN
Chinese Journal of Cardiology 2011;39(9):791-792
Coronary Disease ; drug therapy ; Humans ; Hypolipidemic Agents ; administration & dosage ; therapeutic use
Xian-sheng HUANG ; Shui-ping ZHAO
Chinese Journal of Cardiology 2008;36(8):676-678
Humans ; Inflammation ; Lipoproteins, HDL ; blood ; chemistry
Shui-ping ZHAO ; Da-yi HU
Chinese Journal of Cardiology 2013;41(5):353-356
Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; administration & dosage ; therapeutic use
Min-jie LIN ; Shui-ping ZHAO
Chinese Journal of Cardiology 2012;40(11):979-981
Dyslipidemias ; metabolism ; physiopathology ; Endothelium, Vascular ; physiopathology ; Humans
Li-Juan ZHANG ; Qing-Lin SHUI ; Xiao-Ping ZHAO
Chinese Journal of Applied Physiology 2005;21(3):338-355
Breast Neoplasms ; metabolism ; pathology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Female ; Humans ; Liposomes ; metabolism ; Oligonucleotides, Antisense ; pharmacology ; Proto-Oncogene Proteins c-myc ; metabolism
Shui Ping ZHAO
Chinese Journal of Cardiology 2021;49(6):545-547
Atherosclerosis/prevention & control* ; Cardiovascular Diseases/prevention & control* ; Humans ; Lipids ; Risk Factors